Showing results (1641-1650 of 1,983) with videos related to

Sort By:
Pageof 199
Nutrients|September 12, 2018
Dietary Supplement Use among U.S. Children by Family Income, Food Security Level, and Nutrition Assistance Program Participation Status in 2011⁻2014Shinyoung Jun, Alexandra E Cowan, Janet A Tooze, et al.
Microbial Genomics|July 2, 2025
Evolutionary dynamics in the genome of ocular <i>Chlamydia trachomatis</i> strains from Northern Tanzania following mass drug administrationEhsan Ghasemian, Athumani Ramadhani, Anna Harte, et al.
The Journal of Trauma|April 14, 2006
Effects of hyperglycemia and insulin therapy on outcome in a hyperglycemic septic model of critical illnessJosef G Heuer, Ganesh R Sharma, Tonghai Zhang, et al.
American Journal of Epidemiology|April 4, 2013
Using a nonparametric multilevel latent Markov model to evaluate diagnostics for trachomaArtemis Koukounari, Irini Moustaki, Nicholas C Grassly, et al.
Plos Genetics|May 10, 2006
Pseudo-messenger RNA: phantoms of the transcriptomeMartin C Frith, Laurens G Wilming, Alistair Forrest, et al.
Plos Neglected Tropical Diseases|April 1, 2009
Estimating household and community transmission of ocular Chlamydia trachomatisIsobel M Blake, Matthew J Burton, Robin L Bailey, et al.
Translational Vision Science & Technology|September 1, 2020
Harmonization of Outcomes and Vision Endpoints in Vision Restoration Trials: Recommendations from the International HOVER TaskforceLauren N Ayton, Joseph F Rizzo, Ian L Bailey, et al.
The Oncologist|December 8, 2020
Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or OxaliplatinRudolph M Navari, Kathryn J Ruddy, Thomas W LeBlanc, et al.
Nutrients|August 22, 2018
Dietary Supplement Use Differs by Socioeconomic and Health-Related Characteristics among U.S. Adults, NHANES 2011⁻2014Alexandra E Cowan, Shinyoung Jun, Jaime J Gahche, et al.
Contemporary Clinical Trials|April 24, 2024
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trialMatisyahu Shulman, Scott Provost, Kaitlyn Ohrtman, et al.
Pageof 199